Global in vitro toxicity testing market growth is driven by the increased demand for economical alternatives to animal testing and increased investments in pharmaceutical research and development (R&D). The treatment standards based on chemical and pharmaceutical safety evaluations also boost market growth. The searching for new, non-animal-based techniques for the safety evaluation of drugs and chemicals is increasing the demand for in vitro toxicity testing methods.
Request a Sample Copy of the Report @ https://www.coherentmarketinsights.com/insight/request-sample/3855
Market Trends:
Organ-on-chip microfluidic platforms are increasingly being preferred for testing and conducting research. There is a growth in the application of 3D cell cultures as well as micro physiological systems in the process of toxicity screening. High-throughput screening assays have become commonplace, notably among many academic research and CRO facilities.
Automated high-content screening systems for cancer treatment and developmental toxicity studies are becoming crucial, because drug discovery and development are under such pressure to be quick and inexpensive. Studies into omics technologies and their advancement include transcriptomics, proteomics and metabolomics, which are influencing the mechanism-based studies.
Vitro Toxicity Testing Market Report Coverage
|
Report Coverage |
Details |
|
Market Revenue in 2023 |
$7.8 billion |
|
Estimated Value by 2030 |
$18.9 billion |
|
Growth Rate |
Poised to grow at a CAGR of 13.5% |
|
Historical Data |
2018–2022 |
|
Forecast Period |
2020–2030 |
|
Forecast Units |
Value (USD Million/Billion) |
|
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
|
Segments Covered |
By Type, By End User: |
|
Geographies Covered |
North America, Europe, Asia Pacific, and Rest of World |
|
Growth Drivers |
• Increasing inorganic activities among market players and research institute. |
|
Restraints & Challenges |
• Limitations of in vitro toxicity testing |
Market Opportunity:
In 2023, the reagents and kits segment accounted for the largest share of the in vitro toxicity testing market. This segment has a large share due to growing research activities in vitro toxicity testing, wide applicability of the assay kits in the determination of the toxicity in the drug discovery and development processes. Increasing growth of the reagents and kits increases demand for analytical testing for cosmetic & household products.
Immediate Delivery Available | Buy This Premium Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/3855
Services segment is expected to hold largest share of the market as several pharmaceutical firms are outsourcing these in vitro testing projects. Also, there is an increase in CROs as well as research labs that provide toxicity screening services. Increasing complexity of in vitro tests and the high capital investment needed for in-house testing also favors the services segment.
Key Market Takeaways
Absorption segment will hold the largest share of the market owing to its wide application in determining gastrointestinal absorption and distribution of test substances.
By end user, pharmaceutical industry sector leads the market owing to the stricter safety norms in the development of drugs as well as the increased R&D spending on the in vitro techniques for toxicity screening.
The services segment is projected to be the fastest-growing area during the forecast period. This growth can be attributed to a rising trend of outsourcing in vitro testing projects and an expanding array of toxicity screening services offered by Contract Research Organizations (CROs).
North America is projected to be the leading region during the forecast period due to supportive regulatory policies and concentration of key market players in the region.
Competitor Insights
- Bio-Rad Laboratories Inc.
- Cyprotex
- Convance Inc.
- LifeNet Health LifeSciences
- Creative Bioarray
- Charles River Laboratories
- Intertek Group plc.
- LGC Limited
- Preffered Cell Systems
- Microbac Laboratories Inc.
- Creative Biolabs
Recent Developments:
In January 2023, Charles River Laboratories launched a new suite of in vitro
toxicity testing services. These services aimed at enhancing drug safety
assessments, enabling pharmaceutical companies to streamline their research
processes.
In March 2023, Cyprotex introduced advanced predictive toxicology models that utilize machine learning algorithms to improve the accuracy of toxicity assessments during drug development.
In February 2023, Intertek Group plc expanded its in vitro testing capabilities by adding new assays for assessing skin sensitization, providing clients with comprehensive toxicity testing options.
In April 2023, Creative Bioarray announced the launch of a novel 3D cell culture model specifically designed for in vitro toxicity testing, allowing for more physiologically relevant results in drug safety evaluations.
Ask for Customization @ https://www.coherentmarketinsights.com/insight/request-customization/3855
Detailed Segmentation:
By Type:
- Absorption
- Toxic Substances
- Dose
By End User:
- Cosmetics Industry
- Pharmaceutical Industry
- Food Industry
- Chemicals Industry
By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone:
US: +1-650-918-5898
UK: +44-020-8133-4027
AUS: +61-2-4786-0457
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com
